butyric acid and vancomycin

butyric acid has been researched along with vancomycin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Blaak, EE; Boekschoten, MV; Dejong, CH; Goossens, GH; Groen, AK; Hermes, GD; Holst, JJ; Kootte, RS; Lenaerts, K; Most, J; Neis, EP; Nieuwdorp, M; Olde Damink, SW; Reijnders, D; Smidt, H; van der Beek, CM; Zoetendal, EG	1
Gendo, Y; Hidano, S; Hirose, H; Kamiyama, N; Kobayashi, T; Mizukami, K; Murakami, K; Noguchi, K; Ozaka, S; Ozaki, T; Sachi, N; Saechue, B; Sakai, K; Sonoda, A	1
Chang, EB; Chen, EB; Demsas, F; Eskandari, M; Ho, KJ; Jiang, Q; Layden, BT; Nooromid, M; Priyadarshini, M; Shapiro, K; Xiong, L	1

Trials

1 trial(s) available for butyric acid and vancomycin

Article	Year
Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial. Cell metabolism, 2016, 07-12, Volume: 24, Issue:1 Topics: Adipocytes; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biomarkers; Butyric Acid; Cell Shape; Double-Blind Method; Energy Metabolism; Feces; Gastrointestinal Microbiome; Gene Expression Regulation; Humans; Inflammation; Insulin; Male; Middle Aged; Obesity; Organ Specificity; Permeability; Placebos; Substrate Specificity; Vancomycin	2016

Article

Year

Effects of Gut Microbiota Manipulation by Antibiotics on Host Metabolism in Obese Humans: A Randomized Double-Blind Placebo-Controlled Trial.

Cell metabolism, 2016, 07-12, Volume: 24, Issue:1

Topics: Adipocytes; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biomarkers; Butyric Acid; Cell Shape; Double-Blind Method; Energy Metabolism; Feces; Gastrointestinal Microbiome; Gene Expression Regulation; Humans; Inflammation; Insulin; Male; Middle Aged; Obesity; Organ Specificity; Permeability; Placebos; Substrate Specificity; Vancomycin

2016

Other Studies

2 other study(ies) available for butyric acid and vancomycin

Article	Year
Oral administration of antibiotics results in fecal occult bleeding due to metabolic disorders and defective proliferation of the gut epithelial cell in mice. Genes to cells : devoted to molecular & cellular mechanisms, 2018, Volume: 23, Issue:12 Topics: Administration, Oral; Ampicillin; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Butyric Acid; Carbohydrate Metabolism; Cecum; Cell Line, Tumor; Cell Proliferation; Colon; Colonic Neoplasms; Cytokines; Epithelial Cells; Glutamine; Lipid Metabolism; Macrophages; Metabolic Diseases; Metabolome; Metagenomics; Mice; Microbiota; Occult Blood; RAW 264.7 Cells; Regeneration; Sodium Glutamate; Species Specificity; Vancomycin	2018
Microbe-Derived Butyrate and Its Receptor, Free Fatty Acid Receptor 3, But Not Free Fatty Acid Receptor 2, Mitigate Neointimal Hyperplasia Susceptibility After Arterial Injury. Journal of the American Heart Association, 2020, 07-07, Volume: 9, Issue:13 Topics: Animals; Anti-Bacterial Agents; Bacteria; Butyric Acid; Cell Movement; Cell Proliferation; Disease Models, Animal; Femoral Artery; Gastrointestinal Microbiome; Hyperplasia; Mice, Inbred C57BL; Mice, Knockout; Neointima; Receptors, G-Protein-Coupled; Signal Transduction; Vancomycin; Vascular System Injuries	2020

Article

Year

Oral administration of antibiotics results in fecal occult bleeding due to metabolic disorders and defective proliferation of the gut epithelial cell in mice.

Genes to cells : devoted to molecular & cellular mechanisms, 2018, Volume: 23, Issue:12

Topics: Administration, Oral; Ampicillin; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Butyric Acid; Carbohydrate Metabolism; Cecum; Cell Line, Tumor; Cell Proliferation; Colon; Colonic Neoplasms; Cytokines; Epithelial Cells; Glutamine; Lipid Metabolism; Macrophages; Metabolic Diseases; Metabolome; Metagenomics; Mice; Microbiota; Occult Blood; RAW 264.7 Cells; Regeneration; Sodium Glutamate; Species Specificity; Vancomycin

2018

Microbe-Derived Butyrate and Its Receptor, Free Fatty Acid Receptor 3, But Not Free Fatty Acid Receptor 2, Mitigate Neointimal Hyperplasia Susceptibility After Arterial Injury.

Journal of the American Heart Association, 2020, 07-07, Volume: 9, Issue:13

Topics: Animals; Anti-Bacterial Agents; Bacteria; Butyric Acid; Cell Movement; Cell Proliferation; Disease Models, Animal; Femoral Artery; Gastrointestinal Microbiome; Hyperplasia; Mice, Inbred C57BL; Mice, Knockout; Neointima; Receptors, G-Protein-Coupled; Signal Transduction; Vancomycin; Vascular System Injuries

2020